Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey

↑ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 55 days • 1 price levels

Days at Price

Price Analysis

Most common price: £795 (55 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 55 days

Description

This report was created for global strategic planners who cannot be content with traditional methods of segmenting world markets. With the advent of a "borderless world", cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2,000 cities in over 200 countries. It does so by reporting the estimated market size (in terms of latent demand) for each major city of the world. It then ranks these cities and reports them in terms of their size as a percent of the country where they are located, their geographic region (e.g. Africa, Asia, Europe, Middle East, North America, Latin America), and the total world market. In this report we define the sales of multiple sclerosis drugs as including all commonly understood products falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Acorda Therapeutics, Actelion Pharmaceuticals, arGEN-x SE, Bayer, Biogen, Bristol-Myers Squibb, Celgene Corporation, F. Hoffmann-La Roche, GeNeuro, Hoffmann-La Roche, Innate Immunotherapeutics, Ltd., Inno Bioscience, LLC, Merck & Company, Novartis, Opexa Therapeutics, Pfizer, Sanofi, Teva Pharmaceutical Industries, and TG Therapeutics. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B0B5K9WCF4
Category: Books > Subjects
Domain: Amazon UK
Release Date: 09 June 2022
Listed Since: 11 July 2022

It has never been this cheap. We have no record of a lower price.

The 2023 Report on Multiple Sclerosis Drugs: World Market Segmentation by City

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

Addressing Unmet Medical Needs in Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments

Multiple Sclerosis: Practical Comprehensive Essentials

Emerging Oral Medications for Multiple Sclerosis

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Personalized Management of Multiple Sclerosis

Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)

Multiple Sclerosis: Diagnosis and Therapy

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)

Experimental Models of Multiple Sclerosis

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Frontiers of Targeted Therapy and Predictors of Treatment Response in Systemic Sclerosis

Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis (Topics in Neuroscience)

Lebensqualitat Bei Multipler Sklerose: Berliner Dmsg-Studie

Molecular Biology of Multiple Sclerosis

Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Multiple Sclerosis: Perspectives, Clinical Aspects & Cognitive Challenges (Neurology - Laboratory and Clinical Research Developments)

It has never been this cheap. We have no record of a lower price.

The 2023 Report on Multiple Sclerosis Drugs: World Market Segmentation by City

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

Addressing Unmet Medical Needs in Relapsing-Remitting Multiple Sclerosis

Multiple Sclerosis: Bench to Bedside: Global Perspectives on a Silent Killer: 958 (Advances in Experimental Medicine and Biology, 958)

Multiple Sclerosis Immunology: A Foundation for Current and Future Treatments

Multiple Sclerosis: Practical Comprehensive Essentials

Emerging Oral Medications for Multiple Sclerosis

Advances in Multiple Sclerosis and Experimental Demyelinating Diseases: 318 (Current Topics in Microbiology and Immunology, 318)

Personalized Management of Multiple Sclerosis

Multiple Sclerosis and Associated Demyelinating Disorders, An Issue of Neuroimaging Clinics of North America: Volume 34-3 (The Clinics: Radiology, Volume 34-3)

Multiple Sclerosis: Diagnosis and Therapy

Molecular Basis of Multiple Sclerosis: The Immune System: 51 (Results and Problems in Cell Differentiation, 51)

Neurodegeneration in Multiple Sclerosis (Topics in Neuroscience)

Experimental Models of Multiple Sclerosis

Programmed Cells from Basic Neuroscience to Therapy: 20 (Research and Perspectives in Neurosciences, 20)

Frontiers of Targeted Therapy and Predictors of Treatment Response in Systemic Sclerosis

Magnetic Resonance Techniques in Clinical Trials in Multiple Sclerosis (Topics in Neuroscience)

Lebensqualitat Bei Multipler Sklerose: Berliner Dmsg-Studie

Molecular Biology of Multiple Sclerosis

Nutrition and Lifestyle in Neurological Autoimmune Diseases: Multiple Sclerosis

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Immunotherapies for Neurological Disorders: Unlocking the Brain's Defenses

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis (Topics in Neuroscience)

Neurodegenerative Diseases: Integrative PPPM Approach as the Medicine of the Future: 2 (Advances in Predictive, Preventive and Personalised Medicine, 2)

Building Blocks of Neuroimmunometabolism: From Molecular Pathways to Therapeutic Strategies

Multiple Sclerosis: Perspectives, Clinical Aspects & Cognitive Challenges (Neurology - Laboratory and Clinical Research Developments)